Publication | Open Access

Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial

Neuro-oncologyLymphoid NeoplasiaTransplantationOncologyMedicineMatrix RegimenPrimary Cns LymphomaAutologous TransplantNeurologyCell TransplantationNeuroimmunologyRadiation Oncology